Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease
- Conditions
- STAT1 Gain-of-Function Disease
- Registration Number
- NCT05561985
- Lead Sponsor
- Incyte Corporation
- Brief Summary
Expanded access use of Itacitinib to treat a single patient with aplastic anemia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- AVAILABLE
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Exclusion Criteria
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method